MGRXMangoceuticals, Inc.
0.4326USD-3.91%Mkt Cap: 7.43M USDP/E: Last update: 2026-06-01

Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products …

Indicators:|

Key Statistics

Company
Market Cap7.43M USD
Enterprise Value7.50M USD
Revenue (TTM)414.58K USD
Gross Profit250.39K USD
Net Income (TTM)-20.64M USD
Revenue/Share0.0320 USD
Last Price0.4326 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3
CountryUS
SectorHealthcare
IndustryHealth Information Services
ISIN
Valuation
P/E (Trailing)
P/E (Forward)
PEG
EV/EBITDA-0.47
EV/Revenue18.09
P/S17.81
P/B0.54
EPS (TTM)-1.27
EPS (Forward)
52W Range
0.162010% of range2.750
52W High2.750 USD
52W Low0.1620 USD
Profitability
Gross Margin54.91%
Oper. Margin-4588.41%
EBITDA Margin0.00%
Profit Margin-4526.76%
ROE-135.80%
ROA-128.30%
Growth
Revenue Growth-37.90%
Earnings Growth
Cash Flow & Leverage
Operating CF-5.85M USD
CapEx (TTM)
FCF Margin344.74%
FCF Yield19.24%
Net Debt119.46K USD
Net Debt/EBITDA-0.01
Balance Sheet
Debt/Equity0.02
Current Ratio0.29
Quick Ratio0.24
Book Value/Sh0.7940 USD
Cash/Share0.0100 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:15
Split DateOct 16, 2024
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.17.17M
Float13.43M
Insiders10.04%
Institutions4.81%
Short Interest
Short Ratio0.5d
Short % Float2.50%
Short % Out.2.24%
Shares Short380.69K
Short (prev mo.)926.61K
Technical
SMA 500.3884 (+11.4%)
SMA 2001.104 (-60.8%)
Beta2.12
S&P 52W Chg27.94%
Avg Vol (30d)679.82K
Avg Vol (10d)577.11K
Technical Indicators
RSI (14)54.6
MACD0.0238
MACD Signal0.0145
MACD Hist.+0.0093
BB Upper0.5184 USD
BB Middle0.4034 USD
BB Lower0.2885 USD
BB Width56.99%
ATR (14)0.0598 USD
Vol Ratio (20d)0.30x